Skip to content
DeepViews

Bioceres Crop Solutions Corp. Ordinary Shares (BIOX) — Analysis Summary

Bioceres Crop Solutions Corp. Ordinary Shares (BIOX) has a market cap of $26.16M with year-over-year revenue growth of -27.9%. Net margin stands at -17.6%. The stock trades at a P/E ratio of -0.4.

Key Takeaways

  • Revenue changed -27.9% year-over-year
  • Net margin of -17.6%
  • P/E ratio of -0.4

Compared with its sector, BIOX posted revenue growth of -27.9% and trades at a P/E of -0.4.

[XNAS]

Bioceres Crop Solutions Corp. Ordinary Shares (BIOX)

$0.41

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$26.16M
Enterprise Value
$6.68M
P/E Ratio
-0.4
Div Yield
0.00%
EV/EBITDA
N/A
Company Profile
About
About Bioceres Crop Solutions Corp. Ordinary Shares

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Employees

751

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
52
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$295.22M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$19.49M

Cash Flow

Operating Cash Flow$49.91M
Free Cash Flow$44.26M
FCF Margin13.21%
P/FCF Ratio0.59
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.